Robert Greenlee
On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.
Highest-materiality recent filing
Production mold for SpinDetect consumable disks completed; first-article disks produced and validated after minor modifications.
Lifeloc Q1 net loss narrows to $153K; SpinDetect mold milestone achieved
Net revenue $2.294M (+1% YoY), net loss $153K ($0.06/diluted share) vs $293K loss in Q1 2025.
Lifeloc Technologies enters $500K promissory note with CFO/Chairman for SpinDetect development
Principal $500K, 10.5% initial interest, interest-only payments through Dec 31, 2026.
Lifeloc FY 2025 revenue up 6% to $9.027M; net loss widens to $2.47M on deferred tax charge
Revenue $9.027M (+6% YoY); net loss $2.470M ($0.90/diluted share) vs $1.053M loss in 2024.
Lifeloc Technologies Reports Q3 2025 Revenue Up 8% but Net Loss Widens to $263K
Q3 2025 net revenue $2.257M, up 8% from $2.087M in Q3 2024, but net loss increased to $(263K) from $(158K).
Lifeloc Technologies acquires ELST via merger; exchange ratio 0.048
Each share of ELST common stock will be converted into 0.048 shares of Lifeloc common stock, plus cash for fractional shares.
Net revenue $2.219M, down 7% YoY; net loss $(394k) ($0.14 loss per share) vs $(298k) loss in Q2 2024.
Lifeloc reports FY2024 net loss of $1.05M on revenue down 8% to $8.54M
Net loss of $1.053M ($0.41 diluted EPS) vs net profit of $205.6K ($0.08 EPS) in 2023.
Lifeloc Technologies secures $750,000 subordinated debenture with 8.25% interest and warrants
Issued $750,000 subordinated debenture to Diamond Bridge Capital at 8.25% interest, maturing Dec 31, 2030; quarterly interest through 2025 then monthly P&I.
Lifeloc Q3 2024 net loss $158K, revenue down 23% YoY; SpinDx progress
Q3 net revenue $2.087M (down 23% YoY); net loss $158K ($0.06/diluted) vs prior year profit $110K.
Lifeloc Q2 2024 net loss of $298K; rev $2.387M (+5% YoY); SpinDx beta in 2024
Net loss $(298K) ($0.12/diluted) vs net income $55K ($0.02) in Q2 2023.
Lifeloc raises $798K via private placement, appoints new director, secures $750K credit line
Issued 210,000 shares at $3.80 to EDCO Partners, raising $798K; EDCO now holds 77.5% of common stock.
Lifeloc Q1 net loss widens to $284K; revenue flat at $2.15M
Net revenue $2.153M flat YoY ($2.165M); net loss $(284)K ($0.12/diluted) vs $(54)K loss ($0.02/sh).
Lifeloc reports 2023 revenue $9.33M, net profit $206K vs loss prior year
Net revenue $9.330M (+10% YoY); net profit $206K ($0.08 diluted EPS) vs net loss $456K ($0.19 loss) in 2022.
Lifeloc Q3 net profit $110K, revenue up 33% to $2.696M; SpinDx beta in early 2024
Q3 2023 net profit $110K ($0.04 diluted EPS) vs net loss $(87K) ($(0.04) per share) in Q3 2022.
Lifeloc Q2 2023 net profit $55K vs loss last year; SpinDx beta testing expected in 2023
Quarterly revenue $2.280M, up 5% YoY; net profit $55K ($0.02 diluted EPS) vs loss of $(202)K in Q2 2022.
Lifeloc Tech reports 2022 net loss of $456K despite 20% revenue growth to $8.482M
Revenue $8.482M (+20% YoY); net loss $456K (($0.19)/share) vs net profit $676K ($0.27/share) in 2021.
Lifeloc Q3 net loss $0.04/share vs profit $0.21 YoY; revenue up 8% but supply chain hurts
Revenue $2.032M (+8% YoY); net loss $(87k) vs profit $523k in Q3 2021 (included $471k PPP forgiveness).
Lifeloc Q2 revenue up 26% to $2.18M, net loss widens to $(0.08)/share
Net loss of $202k ($0.08 per share) on revenue of $2.18M, vs net loss of $110k ($0.04 per share) on $1.73M in Q2 2021.
Lifeloc Q1 2022 net loss $145K vs profit $403K in Q1 2021, revenue up 19% to $2.161M
Net loss of $145K ($0.06 diluted EPS) vs. net profit of $403K ($0.16 diluted EPS) in Q1 2021, which included a $465K PPP loan forgiveness gain.
Lifeloc reports Q3 revenue up 21% YoY; net income of $0.21/share vs loss year ago
Q3 2021 net revenue $1.887M (+21% YoY); net income $523k ($0.21 diluted EPS) vs loss of $0.09/share in Q3 2020.
On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.
On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.
Max materiality 0.75 · Median 0.60 · Most common event earnings